Clinical Trial Update: Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial results suggest Provex CV Supplement may reduce inflammation cytokines and lower blood pressure in study participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Provex CV Supplement

Snippet

Sponsor: University of Utah | Conditions: Blood Pressure | Phase 1 | Status: COMPLETED